InvestorsHub Logo
Followers 3052
Posts 148038
Boards Moderated 21
Alias Born 03/01/2004

Re: Murray post# 8144

Saturday, 04/23/2011 11:12:28 AM

Saturday, April 23, 2011 11:12:28 AM

Post# of 30964
i am adding monday my position here ,GLGT is going to pull a major LEG UP from what i see

GLGT has turned into a

Cardiovascular and Infectious Diseases play $$$we are tapping into a multi billion $$$$ market


http://www.glgt-corporate.com/technology.php

Areas of Focus: Cardiovascular and Infectious Diseases

AB (Wuhan) Biotech Co. Ltd. has developed two diagnostic kits or rapid test devices for cardiovascular diseases. The first product in our pipeline is a rapid test device for early diagnosis of acute myocardial infarction (AMI). Another is a test kit for the diagnosis of hypertriglyceridemia.

The best time frame to treat AMI is within the first three hours of it being identified. However, most AMI treatments are delayed due to the limitation of diagnostic tools, poor facilities at small community and rural hospitals in China, and patients' poor self-protective consciousness. Our product is designed to solve those problems.

It's specific, sensitive, simple and fast, with no requirement for any special equipment or apparatus. This provides AMI patients with an efficient, convenient and inexpensive tool to self-test at home, make quick checks in hospital emergency rooms, and enable fast screening tests in community or rural hospitals.